BeStock  
Markets › Compare › BACHY vs AZN

BACHY vs AZN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BACHY · BANK OF CHINA LTD$18.96 ▲ 1.01%
AZN · AstraZeneca$156.53 ▼ 0.24%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

88104120136152Oct 7, '25Apr 7, '26Oct 2, '26
  • BACHY +44.0%
  • AZN -7.1%

Head to head

MetricBACHYAZN
Price$18.96$156.53
Change today▲ 1.01%▼ 0.24%
Market cap$241.85B$242.76B
Return, 3 months+23.5%-18.4%
Return, year to date+36.5%-13.4%
Return, 1 year+43.9%-6.9%
P/E (TTM)7.223.4
P/B0.64.8
P/E percentile vs own 5y–13th
Dividend yield4.30%2.02%
Revenue growth (YoY, latest qtr)–+6.4%
Net profit growth (YoY)–+2.5%
Gross margin–81.9%
Operating margin–22.1%
Net margin–17.0%
Return on equity–22.0%
Analyst target vs. price–+35.5%
Analyst buy share–88%
RSI (14)5137
30-day volatility25.3%22.4%
Max drawdown, 1 year-10.9%-25.3%
Trend readLeaning bullishStrong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AZN is the largest of the group by market value.
  • BACHY has returned the most over the past year.
  • BACHY carries the lowest trailing P/E.
  • BACHY pays the highest dividend yield.
  • AZN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top